bilaterals.org logo
bilaterals.org logo

India FTAs & medicines


Indian pharma cos see hope as US retreats on data exclusivity
A section of India’s generic drug industry has claimed that its ability to export generic drugs to over a dozen countries with which the US is planning FTAs will increase, if a “conceptual agreement” reached last week by the US’ House of Representatives speaker Nancy Pelosi and the Bush administration is ratified and implemented.
Data exclusivity regulations in India
New Indian data exclusivity patenting regulations will severely hinder generic AIDS drugs manufacturing in India, and thus less people will have access to AIDS therapy globally. The world’s poor overwhelmingly make up this population with lack of access. Because of this, moral human rights and distributive justice approaches should compel India to take an equity-oriented approach in access to AIDS medicines and reject data exclusivity regulations currently under discussion.
Patent or patient? How Washington uses trade deals to protect drugs
The controversy over the impact of bilateral trade agreements on public health poses particular difficulties for the Geneva-based WHO, which is gearing up for the highly political election of a new director-general.
South African Custom Union planning for FTA with India
The South African Customs Union is in talks with the Indian government for signing a Free Trade Agreement (FTA) to enhance the trade and business between both the countries.
India set to get access to Bimstec markets
India and the Bay of Bengal Initiative for Multisectoral Technical and Economic Cooperation (Bimstec) member countries plan to sign a deal to provide access to each others’ markets for the pharmaceuticals and services sectors.
IT, biotech, pharmaceuticals, agro food are items for enhanced India-EU cooperation
The Associated Chambers of Commerce and Industry of India sees tremendous scope for enhancing economic ties with Europe and has mooted a four pronged strategy for expanding India’s trade basket with the enlarged EU in areas such as information technology & communication, biotech & pharmaceuticals, agro foods processing and textiles.